Prot #XMAB18087-01: A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb18087 in Subjects with Advanced Neuroendocrine and Gastrointestinal Stromal Tumors

Project: Research project

Project Details

StatusFinished
Effective start/end date8/30/18 → 8/30/23

Funding

  • ICON Clinical Research, LLC (Prot #XMAB18087-01 // Prot #XMAB18087-01)
  • Xencor, Inc. (Prot #XMAB18087-01 // Prot #XMAB18087-01)